The Cancer Cure vs Launch
The Cancer Cure (DARAXONRASIB) and Launch (LAUNCH) compared side by side. Over the past 7 days, DARAXONRASIB is ahead by 38.2 percentage points (DARAXONRASIB -17.6% against LAUNCH -55.8%).
- Ahead over 7 days
- DARAXONRASIB
DARAXONRASIB 0.0%Share of the two combined market caps100.0% LAUNCH
Performance
DARAXONRASIBLAUNCH
- 7 daysDARAXONRASIB
Risk & extremes
| Metric | DARAXONRASIB | LAUNCH |
|---|---|---|
| Max drawdown (400d) | -43.3% | -99.5% |
| Risk-adjusted return (90d) | — | — |